Edwards Lifesciences EPS beats by $0.15, beats on revenue

Edwards Lifesciences (NYSE:EW): Q2 Non-GAAP EPS of $0.34 beats by $0.15; GAAP EPS of -$0.20 beats by $0.10.

Revenue of $925M (-15.1% Y/Y) beats by $133.29M.

FY20 adjusted EPS guidance increased: $1.75-$1.95 from $1.58-$1.75 earlier.

Press Release

https://seekingalpha.com/news/3594507-edwards-lifesciences-eps-beats-0_15-beats-on-revenue